Acute gastrointestinal injury in critically ill patients with COVID-19 in Wuhan, China

Table 1 Demographic data and clinical parameters

Variable	Value
Age (yr)	70 (60-79)
Sex (male: female)	59:24
Days from onset to admission	10 (7-15)
BMI (kg/m2)	23.8 (22.1-25.1)
APACHEII scores	14.0 (12.0-17.0)
SOFA scores	6.0 (4.0-7.0)
Initial symptoms or signs, n (%)
Fever	33 (39.8)
Cough	18 (21.7)
Chest tightness or pain	8 (9.6)
Dyspnea	7 (8.4)
Fatigue	6 (7.2)
Diarrhea	3 (3.6)
Nausea or vomiting	3 (3.6)
Pharyngalgia/myalgia	3 (3.6)
Abdominal pain	2 (2.4)
Laboratory parameters
CRP (mg/L)	85.9 (49.9-136.0)
WBC (109/L)	10.30 (7.44-14.0)
Lymphocyte (109/L)	0.60 (0.43-0.83)
PCT (ng/mL)	0.27 (0.14-0.50)
D-dimer (μg/mL)	8.29 (2.00-14.19)
Lactate (mmol/L)	2.22 (1.68-2.73)
Organ injury, n (%)
ARDS	77 (92.8)
Liver injury	15 (18.1)
AKI	30 (36.1)
Cardiac injury	37 (44.6)
MODS, n (%)	58 (69.9)
Septic shock, n (%)	16 (19.3)
Duration of MV (d)	9.0 (6.0-13.0)
Duration of CRRT (d)	0.0 (0.0-5.0)
Hospital stay (d)	18.0 (11.0-29.0)
Death, n (%)	40 (48.2)

BMI: Body mass index; APACHEII: Acute physiology and chronic health evaluation II; SOFA: Sequential organ failure assessment; CRP: C-reactive protein; WBC: White blood cell; PCT: Procalcitonin; ARDS: Acute respiratory distress syndrome; AKI: Acute kidney injury; MODS: Multiple organ dysfunction syndrome; MV: Mechanical ventilation; CRRT: Continuous renal replacement therapy.